# Bleomycin

NDC: 63323-136
Generic name: BLEOMYCIN SULFATE
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAMUSCULAR, INTRAPLEURAL, INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20090213

FDA application: ANDA065185

## Active ingredients

- BLEOMYCIN SULFATE: 15 [USP'U]/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-136"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-136
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b5806c40-12ce-48e3-8abd-9f8997ef4428